Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin

Drug Development and Industrial Pharmacy

Volumn 35, Issue 2, 2009, Pages 131-137

  Chen, Huanhuan ^a   Jiang, Guoqiang ^a   Ding, Fuxin ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

10 hydroxycamptothecin; Monolithic osmotic tablet; Solid dispersion; Water insoluble

Indexed keywords

10 HYDROXYCAMPTOTHECIN; MACROGOL; MACROGOL 6000; SODIUM CHLORIDE; WATER;

ARTICLE; CONTROLLED RELEASE FORMULATION; DISPERSION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; OSMOTIC PRESSURE; SUSPENSION; TABLET FORMULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; OSMOSIS; POLYETHYLENE GLYCOLS; SODIUM CHLORIDE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 60749129536     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701657388     Document Type: Article

References (20)

1. Appel, L. E., Curatolo, W. J., Herbig, S. M., Nightingale, J. A. S., & Thombre, A. G. (2000). Osmotic system for delivery of solid amorphous dispersions of drugs. European Patent EP1027888.
2. Cortese, R, & Theeuwes, F. (1982). Osmotic device with hydrogel driving member. U.S. Patent 4327725.
3. Craig, D. Q. M. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231, 131-144.
4. Ke, D., & Sun, G.. (2004). The effect of reactive oxygen species on ethylene production induced by osmotic stress in etiolated mungbean seedling. Plant Growth Regul. 44, 149-155.
5. Leuner, C., & Dressman, J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. 50, 47-60.
6. Ling, Y., & Xu, B. (1993). Inhibition of phosphorylation of histone H1 and H3 induced by the 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells. Zhongguo Yao Li Xue Bao 14, 546-550.
7. Liu, L., Ku, J., Khang, G., Lee, B., Rhee, J. M., & Lee, H. B. (2000). Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Control. Release 68, 145-156.
8. Liu, L., Khang, G., Rhee, J. M., & Lee, H. B. (2000). Monolithic osmotic tablet system for nifedipine delivery. J. Control. Release 67, 309-322.
9. Lu, E.-X., Jiang, Z. Q., Zhang, Q. Z., & Jiang, X. G. (2003). A water-insoluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending and expanding agent. J. Control. Release 92, 375-382.
10. Okimoto, K., Tokunaga, Y., Ibuki, R., Irie, T., Uekama, K., & Rajewski, R. A., et al. (2004). Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). Int. J. Pharm. 286, 81-88.
11. Royce, A., Li, S., Weaver, M., & Shah, U. (2004). In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl- 2′-O-methyladenosine. J. Control. Release 97, 79-90.
12. Su Li, Li Z., Zhong zhen G., Zhan J., Yu yan L., Wen qi J. (2005). Absolute bioavailability of hydroxycamptothecin tablets in cancer patient.J. Clin. Pharmacol. 21, 46-49.
13. Theeuwes, F. (1975). Elementary osmotic pump. J. Pharm. Sci. 64, 1987-1991.
14. Theeuwes, F., & Higuchi, T. (1975). Osmotic dispensing device with maximum and minimum sizes for the passageway. U.S. Patent 3916899.
15. Theeuwes, F. (1981). Novel drug delivery systems. In L. F. Prescott & W. S. Nimmo (Eds.), Drug Absorption (pp. 157-176). Balgowlah, Australia: ADIS Press.
16. Urbanetz, N. A., & Lippold, B. C. (2005). Solid dispersions of nimodipine and polyethylene glycol 2000: Dissolution properties and physico-chemical characterization. Eur. J. Pharm. 59, 107-118.
17. Verma, R. K., Mishra, B., & Garg, S. (2000). Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26, 695-708.
18. Verma, R. K., Krishna, D. M., & Garg, S. (2002). Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release 79, 7-27.
19. Gan, Y., Pan, W., Wei, M., & Zhang, R. (2002). Cyclodextrin complex osmotic tablet for glipizide delivery, Drug Dev. Ind. Pharm. 28, 1015-1021.
20. Zhang, R. W., Li, Y. F., Cai, Q. Y., Liu, T. P., & Sun, H. (1998). Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I. Cancer Chemother. Pharmacol. 41, 257-267.